Patent · US Active

Pyrrolopyrimidine compounds and uses thereof

US9346810B2 · kind B2 · utility

10Cited by

0References

6Claims

0Family size

Assignee

HUTCHISON MEDIPHARMA LIMITED · CN

Inventors

Wei-Guo Su · Shanghai, CN
Wei Deng · Shanghai, CN
Jinshui Li · Shanghai, CN
Jianguo Ji · Shanghai, CN

Key dates

Filing date	Aug 18, 2011
Grant date	May 24, 2016
Priority date	—
Expiry date	Apr 9, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/07
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides pyrrolopyrimidine compounds and methods of use therefor. For example, the disclosure provides certain pyrrolopyrimidine compounds capable of inhibiting JAK kinases. The disclosure further provides the pharmaceutical compositions containing these pyrrolopyrimidine compounds, and use of these pyrrolopyrimidine compounds in the treatment of disorders or diseases, such as inflammatory diseases and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.